Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block for Pain After VATS
NCT04208542Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Apr 2019
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Yonsei University. Primary endpoint: Numeric Rating Scale at 48 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04208542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04208542.